Scott A. Gangloff - 29 Apr 2024 Form 3 Insider Report for Akero Therapeutics, Inc. (AKRO)

Signature
/s/ Jonathan Young, Attorney-in-fact
Issuer symbol
AKRO
Transactions as of
29 Apr 2024
Net transactions value
$0
Form type
3
Filing time
01 May 2024, 19:32:20 UTC
Next filing
18 Dec 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney